Longitudinal myelitis in a patient with systemic lupus erythematosus

Joint Bone Spine

Volumn 77, Issue 2, 2010, Pages 181-183

  Richard Mornas, Aurélie ^a   Thomas, Thierry ^a   Pallot Prades, Béatrice ^a   Chopin, Florence ^a   Raoux, Delphine ^b  

^a HÔPITAL NORD   (France)

^b UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

Author keywords

Antiphospholipid antibodies; Central nervous system; Longitudinal myelitis; Systemic lupus erythematosus

Indexed keywords

GLUCOCORTICOID; PHOSPHOLIPID ANTIBODY;

AGED; ARTICLE; BLOODSTREAM INFECTION; BRAIN INJURY; CASE REPORT; CLINICAL FEATURE; DRUG MEGADOSE; FEMALE; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; HUMAN TISSUE; LONGITUDINAL MYELITIS; LUNG EMBOLISM; MYELITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; QUADRIPLEGIA; RARE DISEASE; SPINAL CORD DISEASE; STEREOTACTIC BIOPSY; SYSTEMIC LUPUS ERYTHEMATOSUS; VEIN THROMBOSIS;

AGED; BIOPSY; FATAL OUTCOME; FEMALE; GLUCOCORTICOIDS; HUMANS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MAGNETIC RESONANCE IMAGING; MYELITIS; QUADRIPLEGIA;

EID: 77949571248     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2009.12.006     Document Type: Article

References (13)

1. Appenzeller S., Pike G.B., and Clarke A.E. Magnetic resonance imaging in the evaluation of central nervous system manifestations in systemic lupus erythematosus. Clin Rev Allergy Immunol 34 3 (2008) 361-366
2. Téllez-Zenteno J.F., Remes-Troche J.M., Negrete-Pulido R.O., et al. Longitudinal myelitis associated with systemic lupus erythematosus: clinical features and magnetic resonance imaging of six cases. Lupus 10 12 (2001) 851-856
3. Heinlein A.C., and Gertner E. Marked inflammation in catastrophic longitudinal myelitis associated with systemic lupus erythematosus. Lupus 16 (2007) 823-826
4. Lu X., Gu Y., Wang Y., et al. Prognostic factors of lupus myelopathy. Lupus 17 4 (2008) 323-328
5. Rheu C.W., Lee S.I., and Yoo W.H. A catastrophic-onset longitudinal myelitis accompanied by bilateral internuclear ophtalmoplegia in a patient with systemic lupus erythematosus. J Korean Med Sci 20 6 (2005) 1085-1088
6. Tomietto P., Annese V., D'agostini S., et al. General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus. Arthritis Rheum 57 8 (2007) 1461-1472
7. Valdes-Ferrer S.I., Vega F., Cantu-Brito C., et al. Cerebral changes in SLE with or without antiphospholipid syndrome. J Neuroimaging 18 1 (2008) 62-65
8. Avcin T., Benseler S.M., Tyrrell P.N., et al. A follow-up study of antiphospholipid antibodies and associated neuropsychiatric manifestations in 137 children with systemic lupus erythematosus. Arthritis Rheum 59 (2008) 206-213
9. Brey R.L. Neuropsychiatric lupus: clinical and imaging aspects. Bull NYU Hosp Jt Dis 65 (2007) 194-199
10. Hirano T., Hagiharai K., Kawai M., et al. Successful therapy with steroid and cyclophosphamide pulse for CNS lupus and lupus myelitis. Nihon Rinsho Meneki Gakkai Kaishi 30 (2007) 414-418
11. Lehnhardt F.G., Scheid C., Holtik U., et al. Autologous blood stem cell transplantation in refractory systemic lupus erythematosus with recurrent longitudinal myelitis and cerebral infarction. Lupus 15 (2006) 240-243
12. Sanna G., Bertolaccini M.L., and Khamashta M.A. Neuropsychiatric involvement in systemic lupus erythematosus: current therapeutic approach. Curr Pharm Des 14 13 (2008) 1261-1269
13. Armstrong D.J., McCarron M.T., and Wright G.D. SLE associated transverse myelitis successfully treated with Rituximab. Rheumatol Int 26 (2006) 771-772